Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945274909> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2945274909 endingPage "510" @default.
- W2945274909 startingPage "505" @default.
- W2945274909 abstract "Abstract Medication control in greyhound racing requires information from administration studies that measure drug levels in the urine as well as plasma, with time points that extend into the terminal phase of excretion. To characterize the plasma and the urinary pharmacokinetics of flunixin and enable regulatory advice for greyhound racing in respect of both medication and residue control limits, flunixin meglumine was administered intravenously on one occasion to six different greyhounds at the label dose of 1 mg/kg and the levels of flunixin were measured in plasma for up to 96 hr and in urine for up to 120 hr. Using the standard methodology for medication control, the irrelevant plasma concentration was determined as 1 ng/ml and the irrelevant urine concentration was determined as 30 ng/ml. This information can be used by regulators to determine a screening limit, detection time and a residue limit. The greyhounds with the highest average urine pH had far greater flunixin exposure compared with the greyhounds that had the lowest. This is entirely consistent with the extent of ionization predicted by the Henderson–Hasselbalch equation. This variability in the urine pharmacokinetics reduces with time, and at 72 hr postadministration, in the terminal phase, the variability in urine and plasma flunixin concentrations are similar and should not affect medication control." @default.
- W2945274909 created "2019-05-29" @default.
- W2945274909 creator A5000075483 @default.
- W2945274909 creator A5023377906 @default.
- W2945274909 creator A5034832096 @default.
- W2945274909 creator A5037657912 @default.
- W2945274909 creator A5044527021 @default.
- W2945274909 creator A5047990812 @default.
- W2945274909 date "2019-05-14" @default.
- W2945274909 modified "2023-09-24" @default.
- W2945274909 title "Plasma and urine pharmacokinetics of intravenously administered flunixin in greyhound dogs" @default.
- W2945274909 cites W1521209692 @default.
- W2945274909 cites W1973279862 @default.
- W2945274909 cites W202211084 @default.
- W2945274909 cites W2093370164 @default.
- W2945274909 cites W2109108975 @default.
- W2945274909 cites W2131456325 @default.
- W2945274909 cites W2132033666 @default.
- W2945274909 doi "https://doi.org/10.1111/jvp.12775" @default.
- W2945274909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31090076" @default.
- W2945274909 hasPublicationYear "2019" @default.
- W2945274909 type Work @default.
- W2945274909 sameAs 2945274909 @default.
- W2945274909 citedByCount "2" @default.
- W2945274909 countsByYear W29452749092020 @default.
- W2945274909 crossrefType "journal-article" @default.
- W2945274909 hasAuthorship W2945274909A5000075483 @default.
- W2945274909 hasAuthorship W2945274909A5023377906 @default.
- W2945274909 hasAuthorship W2945274909A5034832096 @default.
- W2945274909 hasAuthorship W2945274909A5037657912 @default.
- W2945274909 hasAuthorship W2945274909A5044527021 @default.
- W2945274909 hasAuthorship W2945274909A5047990812 @default.
- W2945274909 hasBestOaLocation W29452749092 @default.
- W2945274909 hasConcept C10146269 @default.
- W2945274909 hasConcept C112705442 @default.
- W2945274909 hasConcept C126322002 @default.
- W2945274909 hasConcept C185592680 @default.
- W2945274909 hasConcept C2780026642 @default.
- W2945274909 hasConcept C3020079912 @default.
- W2945274909 hasConcept C43617362 @default.
- W2945274909 hasConcept C55493867 @default.
- W2945274909 hasConcept C71924100 @default.
- W2945274909 hasConcept C77411442 @default.
- W2945274909 hasConcept C98274493 @default.
- W2945274909 hasConceptScore W2945274909C10146269 @default.
- W2945274909 hasConceptScore W2945274909C112705442 @default.
- W2945274909 hasConceptScore W2945274909C126322002 @default.
- W2945274909 hasConceptScore W2945274909C185592680 @default.
- W2945274909 hasConceptScore W2945274909C2780026642 @default.
- W2945274909 hasConceptScore W2945274909C3020079912 @default.
- W2945274909 hasConceptScore W2945274909C43617362 @default.
- W2945274909 hasConceptScore W2945274909C55493867 @default.
- W2945274909 hasConceptScore W2945274909C71924100 @default.
- W2945274909 hasConceptScore W2945274909C77411442 @default.
- W2945274909 hasConceptScore W2945274909C98274493 @default.
- W2945274909 hasIssue "5" @default.
- W2945274909 hasLocation W29452749091 @default.
- W2945274909 hasLocation W29452749092 @default.
- W2945274909 hasLocation W29452749093 @default.
- W2945274909 hasLocation W29452749094 @default.
- W2945274909 hasOpenAccess W2945274909 @default.
- W2945274909 hasPrimaryLocation W29452749091 @default.
- W2945274909 hasRelatedWork W1601476979 @default.
- W2945274909 hasRelatedWork W1976743772 @default.
- W2945274909 hasRelatedWork W2023071269 @default.
- W2945274909 hasRelatedWork W2023389637 @default.
- W2945274909 hasRelatedWork W2030105938 @default.
- W2945274909 hasRelatedWork W2078665307 @default.
- W2945274909 hasRelatedWork W2086781832 @default.
- W2945274909 hasRelatedWork W2378109603 @default.
- W2945274909 hasRelatedWork W2417532847 @default.
- W2945274909 hasRelatedWork W297699154 @default.
- W2945274909 hasVolume "42" @default.
- W2945274909 isParatext "false" @default.
- W2945274909 isRetracted "false" @default.
- W2945274909 magId "2945274909" @default.
- W2945274909 workType "article" @default.